SafeliaTM Autoinjector Designed to be Patient and Syringe Friendly.
contributed by Nemera |
Nemera’s has developped a new generation of 2-steps autoinjector for fluid and viscous injections. SafeliaTM autoinjector has been designed to ease patient self-injection experience. SafeliaTM delivers formulations in glass syringes, from fl uid small molecules to challenging highly concentrated biological formulations (viscous, sustain released, larger volumes …) in subcutaneous or intramuscular layers.
Injectable formulations are the fastest growing segment in the pharmaceutical landscape. Biologic therapies are increasingly used to treat a wide range of chronic diseases requiring frequent drug administration over a long period of time. Developing drug delivery devices capable of injecting the pipeline of biological molecules is a challenge as biotherapeutics tend to be more viscous, concentrated and administered in a larger volume.
The injection device should also deliver with possibly less pain, less bruising and over a short delivery time. This can further contribute to issues with patient compliance.
Read the full article now
Log in or register to read this article in full and gain access to The Medicine Maker’s entire content archive. It’s FREE!
Or register now - it’s free!
You will benefit from:
- Unlimited access to ALL articles
- News, interviews & opinions from leading industry experts
- Receive print (and PDF) copies of The Medicine Maker magazine